SMARCB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.105700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.772000E-02
Normal-vs-Stage2
6.348000E-02
Normal-vs-Stage3
3.062600E-01
Normal-vs-Stage4
3.860000E-02
Stage1-vs-Stage2
9.051400E-01
Stage1-vs-Stage3
9.368200E-01
Stage1-vs-Stage4
8.467800E-01
Stage2-vs-Stage3
9.854000E-01
Stage2-vs-Stage4
9.456400E-01
Stage3-vs-Stage4
9.779200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.661800E-02
Normal-vs-AfricanAmerican
5.140000E-03
Normal-vs-Asian
1.397190E-01
Caucasian-vs-AfricanAmerican
7.892000E-01
Caucasian-vs-Asian
9.840600E-01
AfricanAmerican-vs-Asian
9.100800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.407900E-02
Normal-vs-Female
1.923160E-01
Male-vs-Female
1.799030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.433230E-01
Normal-vs-Age(41-60Yrs)
1.574370E-01
Normal-vs-Age(61-80Yrs)
8.490000E-02
Normal-vs-Age(81-100Yrs)
5.099900E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.665400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.514400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.151400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.097000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.835400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.786800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.320300E-02
Normal-vs-Daily Drinker
1.282020E-02
Normal-vs-Weekly Drinker
2.808800E-01
Normal-vs-Occasional Drinker
4.595200E-01
Normal-vs-Social Drinker
1.158430E-02
Non Drinker-vs-Daily Drinker
8.048200E-01
Non Drinker-vs-Weekly Drinker
2.670200E-01
Non Drinker-vs-Occasional Drinker
4.920400E-03
Non Drinker-vs-Social Drinker
7.185400E-01
Daily Drinker-vs-Weekly Drinker
3.102400E-01
Daily Drinker-vs-Occasional Drinker
8.062800E-03
Daily Drinker-vs-Social Drinker
8.795600E-01
Weekly Drinker-vs-Occasional Drinker
7.552200E-01
Weekly Drinker-vs-Social Drinker
3.451400E-01
Occasional Drinker-vs-Social Drinker
2.116400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.606400E-01
Normal-vs-Grade 2
7.452400E-01
Normal-vs-Grade 3
7.392800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.052200E-01
Grade 1-vs-Grade 3
5.004600E-01
Grade 1-vs-Grade 4
7.606400E-01
Grade 2-vs-Grade 3
7.119600E-01
Grade 2-vs-Grade 4
7.452400E-01
Grade 3-vs-Grade 4
7.392800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.308200E-02
Normal-vs-NonDiabetic
1.542000E-01
Diabetic-vs-NonDiabetic
3.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.860100E-03
Normal-vs-NoPancreatitis
1.457830E-01
Pancreatitis-vs-NoPancreatitis
3.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.415410E-01
Normal-vs-N1
8.208100E-02
N0-vs-N1
4.363400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.612000E-01
Normal-vs-TP53-NonMutant
1.182160E-01
TP53-Mutant-vs-TP53-NonMutant
7.009400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
